BORGESON BLAKE sold 0.8% of their position (50K shares) of RECURSION PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $242.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 10/7/2026ACC: 0001601830-26-000120
Director
Since Apr 2021
-50K
Net shares
Net seller
$242.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
50K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−50K
Price / share
$4.84
Trade value
$242K
% of position
0.8%
10/6/2026
6.16M→6.11M
Total
Net shares
−50K
Net value
-$242K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 10/6/2026 | S · Sale | −50K | $4.84 | $242K | 0.8% | 6.16M | 6.11M |
| Total | −50K | -$242K | ||||||
Derivative Transactions0
No derivative transactions reported